scholarly journals    T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody

Haematologica ◽  
2010 ◽  
Vol 96 (3) ◽  
pp. 400-407 ◽  
Author(s):  
M. S. Braza ◽  
B. Klein ◽  
G. Fiol ◽  
J.-F. Rossi
Keyword(s):  
Monoclonal Antibody ◽  
T Cell ◽  
Follicular Lymphoma ◽  
Cell Killing ◽  
Type Ii ◽  
Lymphoma Cells ◽  
Anti Cd20

scholarly journals Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000)

Blood ◽  
2013 ◽  
Vol 122 (7) ◽  
pp. 1137-1143 ◽  
Author(s):  
John Radford ◽  
Andrew Davies ◽  
Guillaume Cartron ◽  
Franck Morschhauser ◽  
Gilles Salles ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Follicular Lymphoma ◽  
Safety Profile ◽  
Clinical Investigation ◽  
Early Stage ◽  
Type Ii ◽  
Acceptable Safety Profile ◽  
Key Points ◽  
Anti Cd20

Key Points Obinutuzumab is a novel type II anti-CD20 monoclonal antibody under early-stage clinical investigation. Obinutuzumab plus CHOP or FC has an acceptable safety profile and is effective in relapsed/refractory follicular lymphoma.

Flow cytometry using the monoclonal antibody CD10-Pe/Cy5 is a useful tool to identify follicular lymphoma cells

2001 ◽  
Vol 66 (2) ◽  
pp. 100-106 ◽  
Author(s):  
M. Bellido ◽  
E. Rubiol ◽  
J. Ubeda ◽  
O. Lopez ◽  
C. Estivill ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Flow Cytometry ◽  
Follicular Lymphoma ◽  
Lymphoma Cells

Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity FcγRIIIa Patients with Previously Treated Follicular Lymphoma

2014 ◽  
Vol 56 (1) ◽  
pp. 42-48 ◽  
Author(s):  
Kristen N. Ganjoo ◽  
Sven de Vos ◽  
Brad L. Pohlman ◽  
Ian W. Flinn ◽  
Andres Forero-Torres ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Follicular Lymphoma ◽  
Phase 1 ◽  
Previously Treated ◽  
Anti Cd20

T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells

1997 ◽  
Vol 15 (4) ◽  
pp. 197-207 ◽  
Author(s):  
Doris Schmitter ◽  
Michael Koss ◽  
Eva Niederer ◽  
Rolf Arno Stahel ◽  
Gabriella Pichert
Keyword(s):  
T Cell ◽  
Follicular Lymphoma ◽  
Germinal Centre ◽  
Lymphoma Cells

Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic Drugs

1997 ◽  
Vol 12 (3) ◽  
pp. 177-186 ◽  
Author(s):  
Aicha Demidem ◽  
Tammy Lam ◽  
Steve Alas ◽  
Kandasamy Hariharan ◽  
Nabil Hanna ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
B Cell ◽  
Cell Line ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Cell Killing ◽  
Cytotoxic Drugs ◽  
Lymphoma Cell ◽  
Lymphoma Cell Line ◽  
Anti Cd20

Weekly x 4 Induction Therapy with the Anti-CD20 Antibody Rituximab: Effect on Circulating t(14;18)+ Follicular Lymphoma Cells

2001 ◽  
Vol 1 (4) ◽  
pp. 293-297 ◽  
Author(s):  
Gabriella Pichert ◽  
Shu-Fang Hsu Schmitz ◽  
Urs Hess ◽  
Thomas Cerny ◽  
Sergio Bruno Cogliatti ◽  
...  
Keyword(s):  
Follicular Lymphoma ◽  
Induction Therapy ◽  
Lymphoma Cells ◽  
Cd20 Antibody ◽  
Anti Cd20

scholarly journals Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells

1999 ◽  
Vol 106 (1) ◽  
pp. 64-70 ◽  
Author(s):  
Doris Schmitter ◽  
Ursula Bolliger ◽  
Michael Hallek ◽  
Gabriella Pichert
Keyword(s):  
T Cell ◽  
Follicular Lymphoma ◽  
Cell Response ◽  
T Cell Response ◽  
Lymphoma Cells
Sign in / Sign up

Export Citation Format

Share Document